Improvement of atopic dermatitis skin symptoms by Vitreoscilla filiformis bacterial extract

European Journal of Dermatology

Volumn 16, Issue 4, 2006, Pages 380-384

  Guéniche, Audrey ^a   Hennino, Anca ^b   Goujon, Catherine ^b   Dahel, Karima ^b   Bastien, Philippe ^a   Martin, Richard ^a   Jourdain, Roland ^a   Breton, Lionel ^a  

^a L ORÉAL RECHERCHE   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Atopic dermatitis; Bacterial extract; Double blind study; mEASI; Pruritus; Vitreoscilla filiformis

Indexed keywords

ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; VITREOSCILLA FILLIFORMIS EXTRACT;

ARTICLE; ATOPIC DERMATITIS; BACTERIUM; BURNING SENSATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ECZEMA; FEMALE; HUMAN; MALE; OINTMENT; RANDOMIZED CONTROLLED TRIAL; SKIN TINGLING; VITREOSCILLA;

ADOLESCENT; ADULT; COMPLEX MIXTURES; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; VITREOSCILLA;

EID: 33748305520     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003; 361: 151-60.
2. Pastore S, Mascia F, Mariotti F, Dattilo C, Girolomoni G. Chemokine networks in inflammatory skin diseases. Eur J Dermatol 2004; 14: 203-8.
3. Management of atopic dermatitis in children. Consensus Conference. Eur J Dermatol 2005; 15: 215-23.
4. Ellis C, Luger T. International consensus conference on atopic dermatitis II (ICAAD II): Clinical update and current treatment strategies. Br J Dermatol 2003; 148(Suppl 63): 3-10.
5. Bos JD. Non-steroidal topical immunomodulators provide skin-selective, self-limiting treatment in atopic dermatitis. Eur J Dermatol 2003; 13: 455-61.
6. In: Holt JG, Krieg NR, Sneath PHA, Staley JT, Williams ST, eds. Bergey's Manual of Determinative Bacteriology. Baltimore: Williams and Wilkins, 1994; (ed. 9th ed., Sections 22 and 23).
7. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol 1989; 144(Suppl.): 13-4; (Stockh).
8. Hanifin JM, Thurston M, Ornoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Exp Dermatol 2001; 10: 11-8.
9. Taïeb A, Stalder JF. Atopic dermatitis: severity scoring. In: Schwindt DA, Maibach HI, eds. Cutaneous biometrics. New York: Kluwer Academic/Plenum Publishers., 2000: 93-107.
10. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945; 1: 80-3.
11. Chapat L, Chemin K, Dubois B, Bourdet-Sicard R, Kaiserlian D. Lactobacillus casei reduces CD8(+) T cell-mediated skin inflammation. Eur J Immunol 2004; 34: 2520-8.